EUCTR2011-001209-28-GB进行中（未招募）不适用
Impact of insulin detemir versus insulin glargine on glycaemic control and metabolism during exercise in Type 1 diabetes - Comparing long-acting insulins during exercise in Type 1 Diabetes
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Participant is willing and able to give informed consent for participation in the study.
- •2.Male or Female, aged between 18 and 65 years
- •3.Diagnosed with Type 1 Diabetes Mellitus (T1DM)
- •4.Treated with a basal bolus regimen using either insulin glargine or insulin detemir as the basal insulin
- •5.Exercising regularly for at least 1 hour per week on average
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.People with any one of the following complications of diabetes:
- •a.stage 2+ diabetic retinopathy
- •b.renal impairment (with creatinine >150micromol/l)
- •c.known history or symptoms of cardiovascular disease
- •d.foot ulceration
- •e.peripheral vascular disease
- •2.Pregnancy or breastfeeding
- •3.Untreated or unstable respiratory disease
- •4.Known hypoglycaemia unawareness
- •5.Treatment with drugs known to interfere with glucose metabolism
- •6.Known or suspected allergy to or intolerance of any of the trial drugs or related products
- •7.Receipt of any investigational drug within four months prior to first appointment
- •8.Known or suspected abuse of alcohol, narcotics or illicit drugs
- •9.Any clinically significant disease or disorder which in the investigator’s opinion could interfere with the results of the trial
研究者
相似试验
进行中（未招募）
1 期
Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes - Detemir vs GlargineType 2 DiabetesEUCTR2005-004754-27-GBCardiff University12
已完成
不适用
Comparison of insulin detemir and insulin glargine on glucose variability in type 1 and type 2 diabetes.diabetes mellitusJPRN-UMIN000001562ational Hospital Organization, Okayama Medical Center30
进行中（未招募）
1 期
A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes (T1D) on a basal bolus regime - A comparison of Insulins Detemir and Glargine in Girls with DiabetesMedDRA version: 9.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitusType 1 diabetesEUCTR2007-004144-74-GBCambridge University Hospitals NHS Foundation Trust97
已完成
3 期
Determir versus Glargine for weight gain in adolescents with type 1 diabetesTopic: Medicines for Children Research Network, Diabetes Research NetworkSubtopic: Type 1, All DiagnosesDisease: All Diseases, Insulin switch, Metabolic, PaediatricNutritional, Metabolic, EndocrineType 1 diabetesISRCTN49492872Cambridge University Hospitals NHS Foundation Trust (UK)97
进行中（未招募）
不适用
Comparison of the effect of insulin detemir and NPH insulin on dawn phenomenon in patients with Type 1 diabetes An open-labelled, randomised, cross-over, multi-center trial comparing the effect of insulin detemir versus NPH insulin as basal insulins on dawn phenomenon and the glycaemic control in patients with Type 1 diabetes treated on a basal-bolus regimen - Dawn phenomenon – insulin detemirType 1 diabetes mellitus, dawn phenomenonEUCTR2005-003877-26-HUational Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit